28 November 20252026 Swiss Chemical Society (SCS) Industrial Science Award for Samuele Cazzamalli, Head of Research at PhilochemDr. Samuele Cazzamalli, Head of Research at Philochem, will be awarded the Industrial Science Award 2026 from the Swiss Chemical Society. His research has focused on the discovery of novel...Read more
11 November 2025The Board of Directors approves the financial position for the third quarter of 2025more detailsRead more
11 November 2025Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa al terzo trimestre 2025more detailsRead more
23 September 2025Il Consiglio di Amministrazione Approva la Relazione Finanziaria Semestrale al 30 giugno 2025 (Price sensitive)more detailsRead more
23 September 2025The Board of Directors Approves the Half-Yearly Financial Report at 30 June 2025 (Price sensitive) – Courtesy English Translationmore detailsRead more
18 August 2025Philochem AG Announces Completion of Antitrust Clearance and Closing of the OncoACP3 Licensing Agreement with RayzeBio, a Bristol Myers Squibb Company, With a Potential Value of up to $1.35 Billion Plus RoyaltiesFor more detailsRead more
18 August 2025La controllata Philochem AG annuncia il completamento del processo autorizzativo antitrust e la conclusione dell’accordo di licenza OncoACP3 con RayzeBio, una società di Bristol Myers Squibb, con un valore potenziale fino a 1,35 miliardi di dollari più royalties.Per maggiori dettagliRead more
